InvestorsHub Logo
Followers 241
Posts 28935
Boards Moderated 1
Alias Born 05/30/2012

Re: None

Thursday, 12/08/2022 9:37:20 AM

Thursday, December 08, 2022 9:37:20 AM

Post# of 232961
Fantastic presentation yesterday. The science of leronlimab will never die, and CytoDyn is destined to greatness as we possess the miracle molecule! Sorry competition.
Expectations for 2023
~ Lifting of partial clinical hold on HIV
~ Financing to fund operations and achieve value inflection
~ Initiating a NASH trial
~ Invest in and advance a long acting CCR5 molecule
~ Continued contributions in medical meetings and peer-reviewed publications
~ Continuing to reshape our team and capabilities to meet our goals
~ Corporate rebranding

Co-development partners especially for oncology again mentioned. Do I hear Samsung? The developments in the Amarex scandal will pay for a ton of scientific development. Now is the best time to be a shareholder for all the prospective new investors the time for waiting is over. I know what I own, I understand the science, I understand the competition, I understand the forces of evil and the greedy FDA. Times are rapidly changing among the medical community and the scientific world is stepping forward finally.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News